青少年对阿片类药物处方家庭用药安全计划的评估：一项定性可用性研究。
Adolescents' assessment of a Family Medication Safety Plan for opioid prescriptions: A qualitative usability study.
出版信息
J Am Pharm Assoc (2003). 2023 Nov-Dec;63(6):1768-1775.e2. doi: 10.1016/j.japh.2023.08.021. Epub 2023 Sep 4.
BACKGROUND
When children are injured or have surgery, parents can be hesitant to fill opioid prescriptions and youth may be concerned about using these medications to manage pain. Parents cite a myriad of reasons why they worry about their child using opioids. The MedSMA℞T Families intervention, which includes a Family Medication Safety Plan (FMSP), is a tool designed to support families in learning and communicating about safe prescription opioid use in their homes and with health care providers.
OBJECTIVE
This study's first aim was to examine adolescents' experiences with using the FMSP. The second aim of this study was to identify opportunities for future improvement.
METHODS
Adolescents, aged 12-18 years, were recruited from April 2021 to October 2021. They were recruited through Qualtrics research panels, email listservs, social media, and snowball sampling. Adolescents reviewed the FMSP and then completed a semistructured follow-up interview with a study team member virtually. The interviews were professionally transcribed verbatim, reviewed by the study team for accuracy, and downloaded into NVivo for analysis. Main themes were identified using content and thematic analysis.
RESULTS
Adolescents (N = 65) reviewed the FMSP and participated in the study. Adolescents found the FMSP to be acceptable and useful for prompting discussions with parents about not only opioids, but all medications being used by the youth. Study participants suggested key improvements such as the creation of a kid-friendly or Spanish language version to improve accessibility and uptake by a diverse population of teens.
CONCLUSION
Adolescents reported that the FMSP would be a helpful tool for their families. Implementing this tool at the point of prescribing or dispensing is a potential strategy to reduce the rates of opioid misuse, reduce hesitancy, and allow adolescents more agency regarding their health care and medication management.
背景
当孩子受伤或接受手术时，父母可能会犹豫是否开阿片类药物处方，而青少年可能担心使用这些药物来缓解疼痛。父母列举了他们担心孩子使用阿片类药物的无数原因。MedSMA℞T Families 干预措施包括家庭用药安全计划 (FMSP)，这是一种旨在支持家庭学习和沟通家庭及医疗保健提供者安全使用处方阿片类药物的工具。
目的
本研究的第一个目的是研究青少年使用 FMSP 的体验。本研究的第二个目的是确定未来改进的机会。
方法
2021 年 4 月至 2021 年 10 月，招募了 12-18 岁的青少年。他们通过 Qualtrics 研究小组、电子邮件列表、社交媒体和滚雪球抽样招募。青少年查看了 FMSP，然后通过虚拟方式与研究团队成员完成了半结构化随访访谈。访谈内容被专业地逐字转录，由研究团队进行准确性审查，并下载到 NVivo 进行分析。使用内容和主题分析确定了主要主题。
结果
65 名青少年（N）审查了 FMSP 并参与了研究。青少年认为 FMSP 是一种可接受的有用工具，可以促使他们与父母讨论不仅是阿片类药物，还有青少年正在使用的所有药物。研究参与者提出了一些关键改进建议，例如创建一个适合儿童或西班牙语的版本，以提高工具对不同青少年群体的可及性和接受度。
结论
青少年报告称，FMSP 将成为他们家庭的有用工具。在开处方或配药时实施该工具是一种潜在的策略，可以降低阿片类药物滥用率，减少犹豫，并使青少年在医疗保健和药物管理方面拥有更多自主权。
Zotero 插件